Compare BOLT & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOLT | TGHL |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 10.5M |
| IPO Year | 2021 | N/A |
| Metric | BOLT | TGHL |
|---|---|---|
| Price | $4.38 | $0.31 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 15.6K | ★ 28.0K |
| Earning Date | 03-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,695,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $56.43 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.07 | N/A |
| 52 Week Low | $0.26 | $0.29 |
| 52 Week High | $7.35 | $3.80 |
| Indicator | BOLT | TGHL |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 42.53 |
| Support Level | $4.42 | $0.29 |
| Resistance Level | $5.01 | $0.51 |
| Average True Range (ATR) | 0.32 | 0.03 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 59.89 | 27.98 |
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
The Growhub Ltd operates at the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, It has developed a multi-faceted approach to address industry challenges. its business currently comprises two main divisions, which are the GrowHub Platform and its product trading facilitation offering.